Quest diagnostics launches advanced pharmacogenomics (pgx) offering

New service empowers clinicians with personalized insights from coriell life sciences to optimize prescribing across specialties secaucus, n.j. , sept. 4, 2025 /prnewswire/ -- quest diagnostics (nyse: dgx), a leading provider of diagnostic information services, today announced an advanced pharmacogenomic (pgx) laboratory test service designed to help providers understand the patient's individual genetic response to select drug therapies.
DGX Ratings Summary
DGX Quant Ranking